Literature DB >> 16782059

HESR1/CHF2 suppresses VEGFR2 transcription independent of binding to E-boxes.

Matthew T Holderfield1, April M Henderson Anderson, Hiroki Kokubo, Michael T Chin, Randy L Johnson, Christopher C W Hughes.   

Abstract

The bHLH transcription factor HESR1 (CHF2) acts downstream of notch to regulate cardiovascular development and angiogenesis, at least in part through down-regulation of the VEGF receptor, VEGFR2. Surprisingly, we find that HESR1 interacts with the promoter in endothelial cells (EC) not through direct binding to the E-boxes, but through intermediary interactions with GC-box-binding proteins. The bHLH and orange domains of HESR1 are sufficient for repression in EC, likely through recruitment of co-repressors, however, the C-terminal YRPW motif is not required. The VEGFR2 promoter contains a functional initiator element but no TATA box, however, addition of a TATA sequence renders the promoter resistant to inhibition by HESR1. In agreement with this finding, the NrCAM, TK, and CMV promoters, which have TATA boxes, cannot be repressed. Thus, HESR1 represses VEGFR2 through interactions with SP-1-like factors and requires an Inr element in the absence of a TATA box. Our findings illuminate an important mechanism for notch/HESR1 regulation of VEGF-induced angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782059     DOI: 10.1016/j.bbrc.2006.05.177

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  How blood vessel networks are made and measured.

Authors:  John C Chappell; David M Wiley; Victoria L Bautch
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

2.  Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting.

Authors:  Lars Jakobsson; Claudio A Franco; Katie Bentley; Russell T Collins; Bas Ponsioen; Irene M Aspalter; Ian Rosewell; Marta Busse; Gavin Thurston; Alexander Medvinsky; Stefan Schulte-Merker; Holger Gerhardt
Journal:  Nat Cell Biol       Date:  2010-09-26       Impact factor: 28.824

3.  The Notch effector Hey1 associates with myogenic target genes to repress myogenesis.

Authors:  Matthew F Buas; Shara Kabak; Tom Kadesch
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

4.  Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.

Authors:  Iqbal Ahmad; Sudha Balasubramanian; Carolina B Del Debbio; Sowmya Parameswaran; Allen R Katz; Carol Toris; Robert N Fariss
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-02       Impact factor: 4.799

5.  Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades.

Authors:  Iván M Moya; Lieve Umans; Elke Maas; Paulo N G Pereira; Karen Beets; Annick Francis; Ward Sents; Elizabeth J Robertson; Christine L Mummery; Danny Huylebroeck; An Zwijsen
Journal:  Dev Cell       Date:  2012-02-23       Impact factor: 12.270

6.  BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.

Authors:  Jai-Hyun Kim; Matthew R Peacock; Steven C George; Christopher C W Hughes
Journal:  Angiogenesis       Date:  2012-05-24       Impact factor: 9.596

Review 7.  Regulation of blood vessel sprouting.

Authors:  John C Chappell; David M Wiley; Victoria L Bautch
Journal:  Semin Cell Dev Biol       Date:  2011-10-14       Impact factor: 7.727

8.  Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation.

Authors:  Yujiro Kida; Joseph A Zullo; Michael S Goligorsky
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

Review 9.  Notch: A multi-functional integrating system of microenvironmental signals.

Authors:  Bryce LaFoya; Jordan A Munroe; Masum M Mia; Michael A Detweiler; Jacob J Crow; Travis Wood; Steven Roth; Bikram Sharma; Allan R Albig
Journal:  Dev Biol       Date:  2016-08-24       Impact factor: 3.582

10.  Gamma-secretase inhibitor DAPT suppresses glioblastoma growth via uncoupling of tumor vessel density from vessel function.

Authors:  Yuhui Zou; Yiqun Cao; Zhijian Yue; Jianmin Liu
Journal:  Clin Exp Med       Date:  2012-07-27       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.